Skip to main content

Gemma Mayayo Marsal

Institutions of which they are part

Research technician
Rheumatology
Vall Hebron Institut de Recerca

Gemma Mayayo Marsal

Institutions of which they are part

Research technician
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Diego Yeste Fernandez

Diego Yeste Fernandez

Senior researcher
Growth and Development
Read more
Xavier Picapiedra Esquivel

Xavier Picapiedra Esquivel

Communication Unit
Communication Directorate
Read more
Montserrat Romero Reinaldos

Montserrat Romero Reinaldos

Research technician
Clinical Neuroimmunology
Read more
Michela Calanni Pileri

Michela Calanni Pileri

Postdoctoral researcher
Maternal and Fetal Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.